EMA increases general, non-pharmacovigilance fees by 0.3 per cent and 5.3 per cent from 1st April, 2022 Read more
Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion Read more
European medicines regulatory network adopts EU common standard for electronic product information Read more
Sacituzumab Govitecan receives positive CHMP opinion as 2L treatment for adult patients with metastatic triple-negative breast cancer Read more